A detailed history of Bayesian Capital Management, LP transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 2,262 shares of BIO stock, worth $724,541. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,262
Previous 3,262 30.66%
Holding current value
$724,541
Previous $890,000 15.06%
% of portfolio
0.09%
Previous 0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$263.97 - $344.64 $263,970 - $344,640
-1,000 Reduced 30.66%
2,262 $756,000
Q2 2024

Aug 14, 2024

BUY
$268.26 - $339.48 $875,064 - $1.11 Million
3,262 New
3,262 $890,000
Q3 2023

Nov 14, 2023

BUY
$350.25 - $422.63 $2.65 Million - $3.2 Million
7,568 New
7,568 $2.71 Million
Q1 2020

May 15, 2020

SELL
$320.01 - $409.07 $961,310 - $1.23 Million
-3,004 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$319.73 - $374.2 $1.06 Million - $1.23 Million
-3,300 Reduced 52.35%
3,004 $1.11 Million
Q3 2019

Nov 13, 2019

SELL
$304.55 - $345.24 $609,100 - $690,480
-2,000 Reduced 24.08%
6,304 $2.1 Million
Q2 2019

Aug 13, 2019

BUY
$286.93 - $312.59 $1.35 Million - $1.47 Million
4,700 Added 130.41%
8,304 $2.6 Million
Q1 2019

May 14, 2019

BUY
$224.3 - $317.41 $201,870 - $285,669
900 Added 33.28%
3,604 $1.1 Million
Q4 2018

Feb 13, 2019

SELL
$220.1 - $309.0 $501,387 - $703,902
-2,278 Reduced 45.72%
2,704 $628,000
Q3 2018

Nov 14, 2018

BUY
$289.28 - $326.15 $867,839 - $978,449
3,000 Added 151.36%
4,982 $1.56 Million
Q2 2018

Aug 14, 2018

BUY
$244.1 - $303.88 $206,020 - $256,474
844 Added 74.17%
1,982 $572,000
Q1 2018

May 15, 2018

SELL
$233.97 - $274.11 $775,610 - $908,674
-3,315 Reduced 74.44%
1,138 $285,000
Q4 2017

Feb 12, 2018

BUY
$216.94 - $271.3 $966,033 - $1.21 Million
4,453
4,453 $1.06 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $7.89B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.